Beverly Bowen Ramsey, CRNA - Medicare Nurse Anesthetist, Certified Registered in Asheville, NC

Beverly Bowen Ramsey, CRNA is a medicare enrolled "Nurse Anesthetist, Certified Registered" in Asheville, North Carolina. Her current practice location is 76 Peachtree Rd, Suite 300, Asheville, North Carolina. You can reach out to her office (for appointments etc.) via phone at (828) 274-3477.

Beverly Bowen Ramsey is licensed to practice in North Carolina (license number 55734) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1730172321.

Contact Information

Beverly Bowen Ramsey, CRNA
76 Peachtree Rd, Suite 300,
Asheville, NC 28803-3395
(828) 274-3477
Not Available



Provider's Profile

Full NameBeverly Bowen Ramsey
GenderFemale
SpecialityNurse Anesthetist, Certified Registered
Location76 Peachtree Rd, Asheville, North Carolina
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1730172321
  • Provider Enumeration Date: 08/30/2005
  • Last Update Date: 01/18/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 9032171137
  • Enrollment ID: I20041101000757

Medical Identifiers

Medical identifiers for Beverly Bowen Ramsey such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1730172321NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367500000XNurse Anesthetist, Certified Registered 55734 (North Carolina)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Beverly Bowen Ramsey allows following entities to bill medicare on her behalf.
Entity NameEast Carolina Health - Heritage Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194703884
PECOS PAC ID: 4789582594
Enrollment ID: O20040702000525

News Archive

Stratatech to advance living human skin substitute tissue clinical trial with $3M funding round

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.

Majority of 9/11 World Trade Center attack survivors report increased incidence of GERS

Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.

Guidelines on atrial fibrillation recommend new approach

Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation.

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

Read more Medical News

› Verified 9 days ago

Entity NameSalem Professional Anesthesia Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538171897
PECOS PAC ID: 9133180326
Enrollment ID: O20041108000480

News Archive

Stratatech to advance living human skin substitute tissue clinical trial with $3M funding round

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.

Majority of 9/11 World Trade Center attack survivors report increased incidence of GERS

Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.

Guidelines on atrial fibrillation recommend new approach

Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation.

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

Read more Medical News

› Verified 9 days ago

Entity NameGreensboro Anesthesia Specialists Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073772612
PECOS PAC ID: 8729129226
Enrollment ID: O20101216000809

News Archive

Stratatech to advance living human skin substitute tissue clinical trial with $3M funding round

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.

Majority of 9/11 World Trade Center attack survivors report increased incidence of GERS

Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.

Guidelines on atrial fibrillation recommend new approach

Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation.

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Beverly Bowen Ramsey is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Beverly Bowen Ramsey, CRNA
76 Peachtree Rd, Suite 300,
Asheville, NC 28803-3395

Ph: (828) 274-3477
Beverly Bowen Ramsey, CRNA
76 Peachtree Rd, Suite 300,
Asheville, NC 28803-3395

Ph: (828) 274-3477

News Archive

Stratatech to advance living human skin substitute tissue clinical trial with $3M funding round

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.

Majority of 9/11 World Trade Center attack survivors report increased incidence of GERS

Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.

Guidelines on atrial fibrillation recommend new approach

Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation.

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

Read more News

› Verified 9 days ago


Nurse Anesthetist, Certified Registered Nurses in Asheville, NC

Bradley Richard Gleckler,
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 509 Biltmore Ave, Asheville, NC 28801
Phone: 828-213-1111    
Kenneth B Walker, CRNA
Nurse Anesthetist - CR
Medicare: Not Enrolled in Medicare
Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803
Phone: 828-254-1969    Fax: 828-254-4611
Mr. Timothy Whalen, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 76 Peachtree Road, Suite 300, Asheville, NC 28803
Phone: 828-254-1969    Fax: 828-274-7407
Emma Greear Autry,
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 509 Biltmore Ave, Asheville, NC 28801
Phone: 828-213-2325    
Angela Michelle Simmons,
Nurse Anesthetist - CR
Medicare: Not Enrolled in Medicare
Practice Location: 76 Peachtree Rd, Suite 300, Asheville, NC 28803
Phone: 828-254-1969    Fax: 828-254-4611
Tamara Ann Matejka,
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 76 Peachtree Road, Suite 300, Asheville, NC 28803
Phone: 828-274-3477    Fax: 828-274-7407
Michael Hector,
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 509 Biltmore Ave, Asheville, NC 28801
Phone: 828-213-1111    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.